APA (7th ed.) Citation

Bertani, E., Fazio, N., Radice, D., Zardini, C., Grana, C., Bodei, L., . . . Falconi, M. (2016). Resection of the Primary Tumor Followed by Peptide Receptor Radionuclide Therapy as Upfront Strategy for the Treatment of G1–G2 Pancreatic Neuroendocrine Tumors with Unresectable Liver Metastases. Annals of surgical oncology, 23(Suppl 5), 981-989. https://doi.org/10.1245/s10434-016-5550-3

Chicago Style (17th ed.) Citation

Bertani, Emilio, et al. "Resection of the Primary Tumor Followed by Peptide Receptor Radionuclide Therapy as Upfront Strategy for the Treatment of G1–G2 Pancreatic Neuroendocrine Tumors with Unresectable Liver Metastases." Annals of Surgical Oncology 23, no. Suppl 5 (2016): 981-989. https://doi.org/10.1245/s10434-016-5550-3.

MLA (9th ed.) Citation

Bertani, Emilio, et al. "Resection of the Primary Tumor Followed by Peptide Receptor Radionuclide Therapy as Upfront Strategy for the Treatment of G1–G2 Pancreatic Neuroendocrine Tumors with Unresectable Liver Metastases." Annals of Surgical Oncology, vol. 23, no. Suppl 5, 2016, pp. 981-989, https://doi.org/10.1245/s10434-016-5550-3.